H. Haddada

发表

p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line

J. Bourhis, G. Vassal, T. Tursz, 2000, British Journal of Cancer.

Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: Role of caspase-8 and mitochondria

G. Kroemer, H. Haddada, F. Mami-Chouaib, 2002, Cancer Gene Therapy.

Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO.

W. Vainchenker, N. Debili, H. Haddada, 1998, Journal of immunology.

Induction of a cytolytic T‐cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

M. Perricaudet, C. Uyttenhove, H. Haddada, 1996, International journal of cancer.

Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma

P. Opolon, H. Haddada, A. Kane, 2003, Cancer Gene Therapy.

High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer.

M. Perricaudet, P. Kourilsky, H. Haddada, 1999, Journal of immunology.

Lipofectamine and related cationic lipids strongly improve adenoviral infection efficiency of primitive human hematopoietic cells.

W. Vainchenker, H. Haddada, T. Byk, 1998, Human gene therapy.

Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery.

M. Perricaudet, H. Haddada, D. Logeart, 2000, Human gene therapy.

LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors.

M. Perricaudet, H. Haddada, V. Descamps, 1996, Gene therapy.

Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages.

M. Perricaudet, H. Haddada, T. Ragot, 1993, Biochemical and biophysical research communications.

Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression

W. Vainchenker, N. Debili, H. Haddada, 1998, Gene Therapy.

γ-Ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells

H. Haddada, A. Kahn, B. Polla,, 1998, Cancer Immunology, Immunotherapy.

Gene therapy using adenovirus vectors.

M. Perricaudet, H. Haddada, L. Cordier, 1995, Current topics in microbiology and immunology.

Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice.

M. Perricaudet, H. Haddada, T. Ragot, 1993, Human gene therapy.

Efficient Local IL-12 Gene Therapy of Cancer the Tumor and Blood Is Associated with T Cells in + High Frequency of Specific CD8

M. Perricaudet, P. Kourilsky, H. Haddada, 2022 .

Strategies for cancer gene therapy using adenoviral vectors

M. Perricaudet, M. Mathieu, H. Haddada, 1996, Journal of Molecular Medicine.

Wild-Type p53 Function Autologous CTL Killing by Restoration of Potentiation of a Tumor Cell Susceptibility to

Isabelle, C. Richon, H. Haddada, 2003 .

IGF‐2 autocrine stimulation in tumorigenic clones of a human colon‐carcinoma cell line

H. Haddada, O. Brison, T. Lamonerie, 1995, International journal of cancer.

Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells.

J. Coligan, H. Haddada, A. Levine, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.

H. Haddada, E. Wattel, C. Preudhomme, 1996, Leukemia.

TGF‐α production correlates with tumorigenicity in clones of the SW613‐S human colon carcinoma cell line

H. Haddada, O. Brison, N. Modjtahedi, 1992 .

Isolation of two immunoglobulin G subclasses, IgG2 and IgG1, from hamster serum using protein A-sepharose.

H. Haddada, M. Escribano, C. de Vaux Saint Cyr, 1982, Journal of immunological methods.

Mitogenic and antimitogenic transforming growth factors secreted by adenovirus 2- and simian virus 40-transformed hamster cells: possible roles in promoting tumorigenesis.

H. Haddada, A. Levine, K. Akagi, 1987, Cancer research.

Novel adenovirus vaccine vectors based on the enteric-tropic serotype 41.

D. Brough, G. Nabel, J. Gall, 2007, Vaccine.

Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-γ delivery is associated with macrophages recruitment and nitric oxide production

M. Ziol, P. Leroy, L. Rénia, 2001, Cancer Gene Therapy.

P73 functionally replaces p53 in Adriamycin‐treated, p53‐deficient breast cancer cells

A. Valent, H. Haddada, S. Tourpin, 2005, International journal of cancer.

Suppressive and cytostatic activities in the spleen of tumor-bearing hamsters.

H. Haddada, C. de Vaux Saint Cyr, 1980, European journal of cancer.

In vivo studies of spleen lymphoid cells implicated in antitumor immunity in hamsters

H. Haddada, A. Duthu, Ch. VauxSaint Cyr, 2004, Cancer Immunology, Immunotherapy.

The neurogene BTG2TIS21/PC3 is transactivated by ΔNp73α via p53 specifically in neuroblastoma cells

E. May, A. Puisieux, H. Haddada, 2005, Journal of Cell Science.

Potentiation of a Tumor Cell Susceptibility to Autologous CTL Killing by Restoration of Wild-Type p53 Function1

C. Richon, H. Haddada, F. Mami-Chouaib, 2003, The Journal of Immunology.

Differential response of p53 target genes to p73 overexpression in SH-SY5Y neuroblastoma cell line

H. Haddada, M. Barrois, A. Legrand, 2004, Journal of Cell Science.

p73α expression induces both accumulation and activation of wt-p53 independent of the p73α transcriptional activity

E. May, H. Haddada, F. Miró-Mur, 2003, Oncogene.

The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector.

M. Perricaudet, H. Haddada, M. A. Abina, 1995, Gene therapy.

Viral gene inhibition of class I major histocompatibility antigen expression: not a general mechanism governing the tumorigenicity of adenovirus type 2-, adenovirus type 12-, and simian virus 40-transformed Syrian hamster cells

J. Coligan, H. Haddada, M. Carbone, 1988, Journal of virology.

Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene.

M. Perricaudet, H. Haddada, J. Sabourin, 1995, Gene therapy.

Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb

C. Badie, H. Haddada, S. Chouaib, 1999, Oncogene.

p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection.

D. Caput, H. Haddada, S. Allart, 2005, Cancer research.

Terrasson J, Allart S, Martin H, Lule J, Haddada H, Caput D et al.. p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection. Cancer Res 65: 2787-2794

D. Caput, H. Haddada, S. Allart, 2005 .

When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 protein.

H. Haddada, S. Douc-Rasy, G. Raguénez, 2003, Cancer letters.

The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.

E. May, A. Puisieux, H. Haddada, 2005, Journal of cell science.

Adenovirus‐mediated wild‐type‐p53‐gene expression sensitizes TNF‐resistant tumor cells to TNF‐induced cytotoxicity by altering the cellular redox state

H. Haddada, S. Chouaib, R. Stancou, 2000, International journal of cancer.

p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.

E. May, H. Haddada, F. Miró-Mur, 2003, Oncogene.

Protein A : a B cell mitogen for hamster splenic lymphoid cells.

H. Haddada, A. Duthu, N. Le Goffic, 1980, Developmental and comparative immunology.